A new publication involving teduglutide appeared on July 29, 2026. The article, titled "Optimizing teduglutide treatment regimens in children with short bowel syndrome," was published in Frontiers in Pediatrics. Teduglutide is an approved compound. This publication is indexed under PubMed ID 42591359. The listed title indicates the article addresses treatment regimen approaches for teduglutide use in pediatric patients with short bowel syndrome. No findings, outcomes, or data from the study are included in this notice. Readers interested in the specific content, methodology, or conclusions of the study should consult the full publication directly through the journal or PubMed listing. This brief serves only to note the existence and basic bibliographic details of the publication, including its title, journal of publication, and publication date. For general background on teduglutide, including its approved status and general information, readers can refer to the compound overview.
New Publication on Teduglutide Regimens in Pediatric SBS
See the full teduglutide overview
Source: https://pubmed.ncbi.nlm.nih.gov/42591359/